Remove BioTech Remove healthcare technology Remove Leadership
article thumbnail

MDisrupt Secures American Heart Association Ventures Investment, Enters Strategic Collaboration for Association Members

Healthcare IT Today

. “Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.” MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.

article thumbnail

Turbine Upsizes its Series A Round to €25.5 Million and Appoints Seasoned Independent Directors to its Board

Digital Health Global

With the additional funding and board appointments, we are set to accelerate the validation of our approach by advancing multiple programs and partnerships toward the ultimate test of any biopharma technology platform – human clinical trials.” Jane Rhodes, Ph.D., Jane Rhodes, Ph.D., Bernd Seizinger, M.D., and Europe.

BioTech 88
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Colin Bower Joins VivoSense as Chief Executive Officer

Digital Health Global

Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.

BioTech 88
article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

Our engagement over the past year in scaling and expanding Koneksa’s medical function, under the leadership of Koneksa Chief Medical Officer Dr. John Wagner, has confirmed that our interests are highly aligned, and we look forward to this next phase of growth.”

article thumbnail

Ellison Institute of Technology campus in Oxford to focus on HealthTech as one of 4 key areas of technological innovation

Lloyd Price

Dedicated Facilities: The new EIT Oxford campus includes over 30,000 square meters of research laboratory space, an oncology and wellness clinic, and facilities like AI GPU Supercluster Lab, Drug Design Lab, and Medical Device Lab, specifically dedicated to healthcare technology advancements. Visit www.nelsonadvisors.co.uk

article thumbnail

Nvidia's Venture Capital Arm in Healthcare: A Strategic Move

Lloyd Price

Recent Investments NVentures has made several notable investments in healthcare startups, including: Hippocratic AI: A company focused on developing safe and effective large language models for healthcare applications. Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Why Healthcare?

BioTech 56
article thumbnail

Wound Care: Emerging HealthTech market to watch in 2025

Lloyd Price

By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.